Trials / Conditions / Acral Lentiginous Melanoma

Acral Lentiginous Melanoma

8 registered clinical trials studyying Acral Lentiginous Melanoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab i NCT04511013	SWOG Cancer Research Network	Phase 2
Terminated	A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies NCT04244552	Atreca, Inc.	Phase 1
Active Not Recruiting	A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and Aft NCT03698019	National Cancer Institute (NCI)	Phase 2
Recruiting	Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease NCT03025256	M.D. Anderson Cancer Center	Phase 1
Terminated	A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ip NCT02978443	Georgetown University	Phase 2
Completed	Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma NCT02875132	Chinese University of Hong Kong	Phase 2
Active Not Recruiting	Dinaciclib in Treating Patients With Stage IV Melanoma NCT00937937	National Cancer Institute (NCI)	Phase 2
Completed	Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma NCT00424515	Dana-Farber Cancer Institute	Phase 2